Healthtech Startups

Arcura is a specialist owner and manager of medical real estate across Europe, providing outpatient healthcare infrastructure to clinical operators. The company applies operational standards and disciplined capital allocation to fragmented healthcare property markets, positioning itself between traditional real estate ownership and direct healthcare operations.

1 investor

Arcutis is a biopharmaceutical company focused on dermatology, developing treatments for immune-mediated skin diseases such as plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis. It serves patients and healthcare professionals with therapies aimed at improving drug efficacy, safety, and tolerability.

1 investor

Ardan Pharma is a biotech company developing small-molecule modulators of the TMEM176A/B cation channel as a targeted cancer immunotherapy for oncology indications with unmet medical needs. Incorporated in Delaware with operations in Uruguay and Argentina, it is advancing drug candidates from pre-IND toward clinical stage.

1 investor

Area9 develops adaptive learning technology and platforms that personalize educational content for individual learners across healthcare, corporate training, and academic sectors. The company was founded in 2006 and builds intelligent learning systems, adaptive sequencers, and content development platforms used by institutions including McGraw-Hill Education, the New England Journal of Medicine, and major corporations.

1 investor

1 investor

Argenta Global is a contract research and manufacturing organization (CRO/CDMO) specializing in animal health, providing comprehensive support across the product development lifecycle from molecule to market for companion and farm animal treatments.

1 investor

Argobio is an operational venture builder in biotechnology sponsored by five strategic investors including venture capital and pharmaceutical partners. The company supports biotech innovation through partnerships with leading healthcare and research organizations.

1 investor

Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.

1 investor

Argonaut Manufacturing Services provides contract manufacturing for life sciences and healthcare products, serving partners across the health and biotech industries with expertise in cGMP manufacturing, regulatory affairs, and operational scaling.

1 investor

Argos Vétérinaire operates a network of veterinary clinics offering in-person animal care, online appointment booking, and Click & Collect ordering of pet products through a partnership with ClubVET Shop. It serves pet owners (dogs, cats, and exotic pets) in France, and also provides pet health insurance and installment payment options in clinic.

1 investor

ARIA develops a head-worn assistive device for blind and vision-impaired users, combining augmented reality audio, novel control interfaces, and AI-powered sensor systems. The company is led by blind subject matter experts and is pursuing regulatory approval as a Class 2a TGA and FDA Class 1 device.

1 investor

Aridhia develops the Digital Research Environment (DRE), a trusted research platform for biomedical and health informatics that enables researchers across multiple countries to collaborate on health research and data-intensive health delivery programs. The platform addresses regulatory compliance, data management, and collaboration challenges in scaling health research initiatives.

1 investor

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers. It offers services such as case managers, radiotherapy, precision health medicine, cancer rehabilitation, and commercial insurance direct billing for patients.

1 investor

ArisGlobal provides software for life sciences research and development, covering drug development, drug safety monitoring, and regulatory compliance. It serves biopharmaceutical companies, CROs, and government health authorities, working with over 220 global life sciences organizations.

1 investor

Seattle 'scientific wellness' startup that paired genetic, blood and microbiome testing with health coaching; closed in 2019.

1 investor

AZ Nutritional is a contract manufacturer of dietary supplements, offering sourcing, formulation, and lab testing services to supplement brands. It positions itself as a manufacturing partner focused on product quality, potency, and third-party verification.

1 investor

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

1 investor

Ark Surgical develops tissue containment systems for minimally invasive gynecological procedures. The company's flagship product is designed to enable safe surgical outcomes in women's health by reducing reliance on open abdominal surgery.

1 investor

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.

1 investor

ArmasTec develops fabric exoskeletons for workers across industrial, hospitality, and healthcare sectors. The company aims to make wearable exoskeleton technology widely accessible for manual work across diverse industries.

1 investor

ARMGO develops a novel class of therapeutics called Rycals that target ryanodine receptors (RyRs) to correct calcium channel dysfunction in serious diseases with high unmet need. Its lead candidate, Surlorian, is being developed for heart failure by addressing an underlying driver of disease progression.

1 investor

ARMR Sciences is developing conjugate vaccines and biologic countermeasures, including its lead candidate ARMR-100, designed to bind fentanyl in the bloodstream and prevent overdose from synthetic drugs. It targets high-risk populations such as first responders, military personnel, and individuals in recovery, working on a platform approach to address emerging drug threats.</parameter> <parameter name="sector_codes">["biotech", "healthtech", "deeptech"]

1 investor

ARNA Genomics US develops liquid biopsy multiomics diagnostic technologies, with a current focus on ARNA Breast, an assay for early-stage breast cancer detection. The company operates as a research diagnostic laboratory conducting clinical trials on its cancer marker tests.

1 investor

Aroa Biosurgery Limited manufactures medical devices, including Endoform, for surgical applications with coverage under Medicare reimbursement policies.

1 investor